Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1

Rheumatol Int. 1987;7(1):35-41. doi: 10.1007/BF00267340.

Abstract

Supernatant media from cultured human mononuclear blood leukocytes (MCCM) induced morphological changes in normal human synovial fibroblasts in culture, including the formation of cells with a dendritic or stellate morphology and, less frequently, cells with a striking fenestrated appearance. These changes were fully reversed within 1 h of removing the MCCM. They were inhibited by indomethacin, the glucocorticoids hydrocortisone, prednisolone and dexamethasone, and by colcemid, but not by actinomycin D and only weakly by cycloheximide. The morphological responses to MCCM could be reproduced by MCCM fractions containing interleukin 1-like activity and by purified forms of human interleukin 1 (IL-1), including monocyte-derived IL-1 beta and recombinant IL-1 alpha. These responses were also inhibited by indomethacin, indicating a link with prostanoid production. However, the morphological responses were not related to the stimulation of plasminogen activator activity due to MCCM, MCCM fractions, or IL-1.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Demecolcine / pharmacology
  • Fibroblasts / cytology*
  • Fibroblasts / drug effects
  • Glucocorticoids / pharmacology
  • Humans
  • Indomethacin / pharmacology
  • Interleukin-1 / physiology*
  • Lymphocytes / physiology*
  • Monocytes / physiology*
  • Plasminogen Activators / physiology*
  • Prostaglandins / biosynthesis
  • Synovial Membrane / cytology*
  • Urokinase-Type Plasminogen Activator / pharmacology

Substances

  • Glucocorticoids
  • Interleukin-1
  • Prostaglandins
  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator
  • Indomethacin
  • Demecolcine